Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients?

Article

Abstract: Cellular and humoral response to acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is

Palabras claves:

adoptive immunotherapy, covid-19, lymphocyte expansion, respiratory virus, SARS-COV-2, third-party donors, virus-specific T cells

Autores:

Aguado C., Aguilar-Gallardo C., Alberto Louro, Arbona C., Balaguer-Rosello A., Carrasco M.P., de la Rubia J., Francés-Gómez C., Geller R., Gómez M.D., Gómez-Segui I., González-Barberá E.M., Guerreiro M., Larrea L., Latorre V., Luis Piñana J., Luna I., Montoro J., Perla A., Planelles D., Sanz G., Sanz J., Sanz M.Á., Sempere A., Solves P.

Fuentes:

scopus